Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cistron Biotechnology(CIST)$.30 -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (1288)	7/20/1998 6:45:00 PM
From: Steve Harmon	Read Replies (1) \| Respond to of 2742

Richard, I understand your concerns on the science based fundamentals. Galton has dropped the ball several times there. I have of course been concentrating on the finance fundamentals. The way the financial consultant terms were set up with Bluestone was terrible for the shareholder. Bluestone of course does not want the price of Cistron's stock to go higher until they get the strike price on the other 400,000 warrants. Therefore no stock support has been given to CIST's price in almost a year. Of course with $12.6 million in cash a small open market buyback could give our shares much needed support also. If Bruce G. would have been wiser in the above two areas the value of our shares would be 3-4 times higher than where we currently are trading minimum. Steve

To: scaram(o)uche who wrote (1288)	7/21/1998 11:29:00 PM
From: Steve Harmon	Read Replies (2) \| Respond to of 2742

Richard, Can you believe that Cistron actually has a $1 million dollar "key man" life insurance policy on Bruce? That would be equivalent to Andy Griffith having a $1 million "key man" policy on Barney Fife! Steve